MIT Technology Review Subscribe

23andMe Expands its Data Mining Operations

The personal genetics company purchased disease-community website CureTogether earlier this week.

Personal genetics company 23andMe bought a patient social networking site called CureTogether earlier this week, a move that will expand the Silicon Valley-based company’s ability to mine data from its patients for its own research.

CureTogether is an online forum with some 25,000 members who share information about their illness, and personal anecdotes about the effects of treatments and lifestyle choices on their symptoms.

Advertisement

23andMe sells DNA tests directly to consumers who send a spit sample to the company for genomic screening of up to 1 million genetic variants, which are a mix of both recreational (e.g. the genetic basis for tongue rolling) and serious medical traits (e.g. genetic factors associated with Parkinson’s Disease) as well as variants that indicate a customer’s ancestry.

This story is only available to subscribers.

Don’t settle for half the story.
Get paywall-free access to technology news for the here and now.

Subscribe now Already a subscriber? Sign in
You’ve read all your free stories.

MIT Technology Review provides an intelligent and independent filter for the flood of information about technology.

Subscribe now Already a subscriber? Sign in

The amount of the purchase was not reported and is 23andMe’s first acquisition, according to the San Francisco Business Times.

This is your last free story.
Sign in Subscribe now

Your daily newsletter about what’s up in emerging technology from MIT Technology Review.

Please, enter a valid email.
Privacy Policy
Submitting...
There was an error submitting the request.
Thanks for signing up!

Our most popular stories

Advertisement